| Sandra Culbertson, MD | |
|
100 N Academy Ave, Danville, PA 17822-1447 | |
| (570) 271-6298 | |
| (570) 271-5841 |
| Full Name | Sandra Culbertson |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 37 Years |
| Location | 100 N Academy Ave, Danville, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962419788 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisinger Medical Center | Danville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geisinger-hm Joint Venture Llc | 1355676370 | 306 |
| Geisinger Clinic | 5395657001 | 2866 |
News Archive
Researchers at NYU Grossman School of Medicine in New York have conducted a study demonstrating the effectiveness of the Pfizer-BioNtech BNT162b2 vaccine against recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
The Federation of State Medical Boards (FSMB) House of Delegates adopted new policy guidelines on the appropriate use of social media and social networking sites by physicians during the FSMB's 2012 Annual Meeting in Fort Worth, Texas, on April 28.
Agricultural subsidies are responsible for making those processed and energy-dense foods that contribute to the American epidemic of obesity the most affordable options for consumers, concludes a new study led by Dr. Mark J. Eisenberg, a cardiologist and epidemiologist at the Lady Davis Institute at the Jewish General Hospital in Montreal.
New research from the University of California, San Francisco suggests that the citrate and malate content in commonly consumed sodas may be sufficient to inhibit the development of calcium stones. The study was presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA).
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009. For the six months ended June 30, 2010, the aggregate partner company revenue was $176.9 million, up 45% from $121.8 million for the same partner companies for the same period of 2009.
› Verified 7 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Researchers at NYU Grossman School of Medicine in New York have conducted a study demonstrating the effectiveness of the Pfizer-BioNtech BNT162b2 vaccine against recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
The Federation of State Medical Boards (FSMB) House of Delegates adopted new policy guidelines on the appropriate use of social media and social networking sites by physicians during the FSMB's 2012 Annual Meeting in Fort Worth, Texas, on April 28.
Agricultural subsidies are responsible for making those processed and energy-dense foods that contribute to the American epidemic of obesity the most affordable options for consumers, concludes a new study led by Dr. Mark J. Eisenberg, a cardiologist and epidemiologist at the Lady Davis Institute at the Jewish General Hospital in Montreal.
New research from the University of California, San Francisco suggests that the citrate and malate content in commonly consumed sodas may be sufficient to inhibit the development of calcium stones. The study was presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA).
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009. For the six months ended June 30, 2010, the aggregate partner company revenue was $176.9 million, up 45% from $121.8 million for the same partner companies for the same period of 2009.
› Verified 7 days ago
| Entity Name | Geisinger-hm Joint Venture Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144876137 PECOS PAC ID: 1355676370 Enrollment ID: O20190826000803 |
News Archive
Researchers at NYU Grossman School of Medicine in New York have conducted a study demonstrating the effectiveness of the Pfizer-BioNtech BNT162b2 vaccine against recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
The Federation of State Medical Boards (FSMB) House of Delegates adopted new policy guidelines on the appropriate use of social media and social networking sites by physicians during the FSMB's 2012 Annual Meeting in Fort Worth, Texas, on April 28.
Agricultural subsidies are responsible for making those processed and energy-dense foods that contribute to the American epidemic of obesity the most affordable options for consumers, concludes a new study led by Dr. Mark J. Eisenberg, a cardiologist and epidemiologist at the Lady Davis Institute at the Jewish General Hospital in Montreal.
New research from the University of California, San Francisco suggests that the citrate and malate content in commonly consumed sodas may be sufficient to inhibit the development of calcium stones. The study was presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA).
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009. For the six months ended June 30, 2010, the aggregate partner company revenue was $176.9 million, up 45% from $121.8 million for the same partner companies for the same period of 2009.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sandra Culbertson, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Sandra Culbertson, MD 100 N Academy Ave, Danville, PA 17822-1447 Ph: (570) 271-6298 |
News Archive
Researchers at NYU Grossman School of Medicine in New York have conducted a study demonstrating the effectiveness of the Pfizer-BioNtech BNT162b2 vaccine against recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
The Federation of State Medical Boards (FSMB) House of Delegates adopted new policy guidelines on the appropriate use of social media and social networking sites by physicians during the FSMB's 2012 Annual Meeting in Fort Worth, Texas, on April 28.
Agricultural subsidies are responsible for making those processed and energy-dense foods that contribute to the American epidemic of obesity the most affordable options for consumers, concludes a new study led by Dr. Mark J. Eisenberg, a cardiologist and epidemiologist at the Lady Davis Institute at the Jewish General Hospital in Montreal.
New research from the University of California, San Francisco suggests that the citrate and malate content in commonly consumed sodas may be sufficient to inhibit the development of calcium stones. The study was presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA).
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009. For the six months ended June 30, 2010, the aggregate partner company revenue was $176.9 million, up 45% from $121.8 million for the same partner companies for the same period of 2009.
› Verified 7 days ago
Kristin Lorraine Martin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6298 Fax: 570-271-5841 | |
Dr. Latif L. Awad, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6298 | |
Dr. Diane De Lisi Timms, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6298 Fax: 570-271-5841 | |
Dr. Brytanie Nicole Marshall, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 North Academy Ave., Danville, PA 17822 Phone: 570-271-6298 Fax: 570-271-5841 | |
Dr. Ekaterina Halivelakis, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6211 | |
Dr. Deborah A. Poplawsky, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6298 | |
Kajal Angras, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 North Academy Ave, Danville, PA 17822 Phone: 570-271-6298 Fax: 570-271-5841 |